Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-04-28

FDA Approved: RISEDRONATE SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for risedronate sodium, resulting in updated labeling. This action confirms the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risedronate sodium (generic) (Risedronate sodium)

Snippet

SUPPL AP for RISEDRONATE SODIUM (RISEDRONATE SODIUM)